PCSK9 and cardiovascular disorder: Thus, the purpose of our study is to examine the effect of PCSK9 inhibitors and siRNA therapies on major adverse cardiac events and degree of LDL reduction in patients with cardiovascular disease and those at high risk of cardiovascular disease.